OTC Oral Contraceptive Interest Could Be Price Sensitive, Study Suggests
Executive Summary
You may also be interested in...
Oral Contraceptive OTC Proposal Moves Closer With Start Of Actual Use Study
HRA Pharma started recruiting in April for an actual use trial, using oral contraceptives with norgestrel 0.075 mg, and expects to complete its study in April 2019, according to clinicaltrials.gov's database. Advocacy group Ibis Reproductive Health, which is working with HRA on an NDA for an OTC oral contraceptive, called the start of the study a "pivotal moment" in moving birth control drugs out of Rx-only.
Oral Contraceptive OTC Proposal Moves Closer With Start Of Actual Use Study
HRA Pharma started recruiting in April for an actual use trial, using oral contraceptives with norgestrel 0.075 mg, and expects to complete its study in April 2019, according to clinicaltrials.gov's database. Advocacy group Ibis Reproductive Health, which is working with HRA on an NDA for an OTC oral contraceptive, called the start of the study a "pivotal moment" in moving birth control drugs out of Rx-only.
AMA Encourages Oral Contraceptive OTC Options In Policy Update
AMA members agree to strengthen association's policy language supporting approval and reimbursement of OTC contraceptives.